tarenflurbil has been researched along with ly 411575 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kreft, AF; Martone, R; Porte, A | 1 |
| Dannhardt, G; Dehm, F; Flesch, D; Hieke, M; Lamers, C; Ness, J; Ogorek, I; Popella, S; Schubert-Zsilavecz, M; Steri, R; Weggen, S; Werz, O | 1 |
| Golshayan, D; Juillerat-Jeanneret, L; Kumar, R | 1 |
2 review(s) available for tarenflurbil and ly 411575
| Article | Year |
|---|---|
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Drug Discovery; Humans; Models, Biological; Protease Inhibitors | 2009 |
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.
Topics: Amyloid Precursor Protein Secretases; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Carcinogenesis; Clinical Trials as Topic; Fibrosis; Genes, Tumor Suppressor; Humans; Inflammation; Ligands; Neoplasms; Receptors, Notch; Signal Transduction | 2016 |
1 other study(ies) available for tarenflurbil and ly 411575
| Article | Year |
|---|---|
SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Arachidonate 5-Lipoxygenase; Caproates; Humans; Lipoxygenase Inhibitors; PPAR gamma; Structure-Activity Relationship | 2015 |